BioSpace News Archive

FDA

FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease

FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease.

February 4, 2022
·
8 min read
Deals

Nuo Therapeutics Responds to Mini-Tender Offer

Nuo Therapeutics, Inc. (“Nuo” or the “Company”) announced that it is aware of an unsolicited “mini-tender” offer by Alternative Liquidity Index, LP to purchase up to 1,820,000 shares of Nuo common stock, approximately 4.9% of the outstanding shares, at $0.01 per share.

February 4, 2022
·
4 min read
Business

Calidi Biotherapeutics Announces Appointment of Alfonso “Chito” Zulueta, Former President of International for Eli Lilly, to Its Board of Directors

Calidi Biotherapeutics, Inc. announced today the appointment of Alfonso “Chito” Zulueta to its Board of Directors, effective February 7, 2022.

February 4, 2022
·
9 min read
Deals

Genesis MedTech Acquires JC Medical, Creates New Structural Heart Franchise

Genesis MedTech Group has completed the acquisition of JC Medical, a structural heart company that is primarily engaged in the design and development of transcatheter valve replacement products for the minimally invasive treatment of structural heart diseases.

February 4, 2022
·
3 min read